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Background: Review of other epidemiological studies reveal inconsistent results of relationships between high
blood lead level and risk of hypertension, hyperlipidemia and hyperglycemia. In this study we wanted to find if
there is a relationship between blood lead level and these ischemic heart disease risk factors.
Methods: This cross-sectional study was conducted in a battery recycling plant, and 497 male workers with the
mean age of 41.7 (±6.50) years were recruited from all over the plant (those from the products and maintenance
sections were classed as “high lead exposed group” and those from amongst the office, laboratory, security services
and food services sections as “low lead exposed group”). Personal information such as demographics and work
history was obtained through a questionnaire.
Mean (±Standard deviation) for quantitative variables, Frequency (Percent) for qualitative variables, and Odd’s ratio
(OR) with 95% confidence interval (95% CI) for estimating the effect of blood lead level on lipid profile[triglyceride
(TG), cholesterol(CHOL), low density lipoprotein – Cholesterol(LDL-C),high density lipoprotein –Cholesterol(HDL-C)],
hypertension(HTN) and fasting blood sugar (FBS) level. Logistic regression modeling was used for multivariate
analysis and adjusting the effect of different variables (age, body mass index(BMI), eating habits, cigarette smoking).
Results: The mean Blood Lead Level (BLL) was >40 μg/dl in 281 (56.6%) subjects, ≤40 μg in 216 (43.4%) subjects
and the mean BLL was 43.3 μg/dl (n = 497). The mean job experience involving lead exposure was 13 years. There
was no significant correlation between BLL and FBS (p = 0.68), between BLL and TG (P = 0.32), between BLL and
HDL-C (p = 0.49), between BLL and LDL-C (p = 0.17), between BLL and CHOL(p = 0.96), between BLL and systolic
blood pressure (p = 0.12). The adjusted Odd’s ratio for the effect of BLL >40.0 μg/dl on diastolic blood pressure
was1.03 (95% CI: 1.01–1.05) with p = 0.05.
Conclusion: This study showed an association of high BLL with diastolic blood pressure but not with TG, FBS, and
HDL-C, LDL-C and CHOL . This result persisted even after adjustment was made for age, BMI and job experience,
smoking and eating habits. Attention to health-protective policies, individual behavioral changes and regular
periodic medical examination with focus on diastolic blood pressure in lead exposed workers is likely to decrease
the public health burden of ischemic heart disease.
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The major risk factors in Ischemic Heart Disease (IHD)
are physical inactivity, high serum lipids/cholesterol,
hypertension, family history of IHD, obesity, smoking
and gender. Environmental pollution and occupation
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distribution, and reproduction in any mediummercury and cobalt) have also been known to contribute
to cause or to exacerbate IHD. Lead is a heavy metal
and is widely used in various industrial processes. One
of the major uses of lead is in batteries manufacturing/
recycling units for automobile industry. Workers in a
battery manufacturing plant are easily exposed to lead.
Exposure occurs through inhalation, ingestion or occa-
sionally by direct skin contact. It is a toxic substance
and affects every one of the body’s organ systems. It
adversely affects not only the nervous system, but also thetral Ltd. This is an Open Access article distributed under the terms of the
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mopoetic system, and reproductive systems [1]. Hearing
loss and tooth decay have been linked to lead exposure
[2,3].
Lead is also considered as one of the contributing
factors to hypertension [4]. However, recent study has
revealed the effect of lead on arterial blood pressure at
levels not causing clinical symptoms of renal impair-
ment [5]. Cumulative low-level lead exposures are
associated with elevated blood pressure and thereby
may increase the risk of atherosclerotic cardiovascular
disease [6]. Many in vitro and in vivo studies have
shown the possible mechanisms by which lead expos-
ure can raise arterial pressure. These are: by pro-
moting oxidative stress and inflammation, disturbing
NO (Nitrous Oxide) signaling pathways, altering major
vasoregulatoy systems, damaging endothelial lining,
promoting vascular smooth muscle cells(VSMC) pro-
liferation and transformation, and inhibiting fibrinoly-
sis, [7-14]. The effects of lead poisoning in diabetes
subjects have been recognized [15-17]. Epidemiological
and experimental studies in animals have shown lead
toxic effects at high levels of exposure and it is
possible that high blood concentration of lead may
contribute progression of diabetic complications in
diabetic patients [16,18,19].
The aim of the present epidemiological study was
to investigate whether blood lead level is associa-
ted with lipid, fasting blood sugar and hypertension
disturbances.
Material and methods
A cross-sectional study was conducted among 497 male
workers of a recycling battery manufacturing plant. The
questions covered various aspects of working conditions,
smoking habits, and family history of hypertension,
diabetes, hyperlipidemia, and hypothyroidism. Hyper-
tension was defined as having a systolic blood pressure
of 140 mmHg or more, or a diastolic blood pressure of
90 mmHg or more and or answering “yes” about being
on antihypertensive medication. Body weight and
height were measured in light indoor clothing and
recorded to the nearest kilogram. and nearest centi-
meter respectively. Body mass index (BMI) was cal-
culated and those with a BMI of 30 or more were
classified as obese. 233 workers who had direct lead
exposure from the products and maintenance parts
were classed as “high lead exposed group” and 264
workers was selected from amongst the office workers,
lab technicians, security services and food services of
the factory as “reference group”. These workers were
not exposed to lead.
After an overnight fasting of 12 hours, blood samples
were collected between 08:00–10:00 hrs for BLL andother biochemical analysis. Total cholesterol, triglycer-
ides and HDL-cholesterol concentration were measured.
Aliquots of blood samples were separated for lead
analysis which was measured by atomic absorption
spectrophotometer and the remaining blood samples
were centrifuged to separate plasma and red blood cells.
Serum triglycerides, cholesterol and FBS levels were
measured by enzymatic assays, HDL and LDL by direct
immuno turbidometry assays (Pars-Azmun, Tehran,
Iran). Triglyceride value >200 mg/dl, HDL-cholesterol
<45 mg/dl, Cholesterol > 200 mg/dl, LDL > 130 mg/dl
were defined as lipid disturbances.
The study protocol was approved by the Ethical
Committee of the Occupational Medicine Depart-
ment Tehran University of Medical Sciences, Tehran,
Iran.
The SPSS software version 16 was used for statistical
analysis. Mean (±Standard deviation),for quantitative
variables, Frequency (Percent) for qualitative variables,
and Odd’s ratio (OR), and 95% confidence interval
(95% CI) was used for estimating the effect of blood
lead level on lipid profile, hypertension and high blood
glucose levels. Logistic regression modeling was used
for multivariable analysis and adjusting the effect of
different variables (age, BMI, eating habits, cigarette
smoking).
Results
The total of 497 battery recycling male workers were
consisting of 281 (56.6%) with BLL >40 μg/dl and 216
(43.4%) with BLL ≤40 μg/dl. The mean age of the
workers was 41.7 ± 6.5 years. The mean duration of job
experience of the workers was 12.90 ± 7.00 years. Mean
blood lead level was 43.31 (7–94) μg/dl ± 17.95.
Table 1 shows the result of mean of the cardiovascular
variables in 2 groups (group1: BLL > 40 μg/dl and group2:
BLL ≤ 40 μg/dl).
Table 2 shows the result of mean of the cardiovascular
variables in all workers.
Table 3, shows the results of the relative risks for
different variables in two groups (group1: BLL > 40 μg/dl
and group2: BLL ≤ 40 μg/dl).
Conclusions
Lead is a common environmental pollutant. Causes of
environmental contamination include industrial use of
lead, such as is found in plants that process lead-acid
batteries or produce lead wire or pipes, and metal recyc-
ling and foundries.
This study showed that high diastolic blood pressure
was more common in workers with BLL > 40 μg/dl than
in workers with BLL ≤ 40 μg/dl (Odds ratio1.03 (95% CI:
1.01–1.05), p = 0.05). This finding persisted after adjust-
ment was made for age, BMI, job experiences and
Table 1 Mean of variables in 2 groups(group1:
BLL > 40 μg/dl and group2: BLL ≤ 40 μg/dl)
Variables Group1 Group2
Fasting Blood Sugar 86.75 91.43
Triglyceride 155.90 172.95
Cholesterol 191.60 190.70
LDL-C 115.94 119.43
HDL-C 40.90 41.00
SystolicBlood Pressure 119.68 118.40
Diastolic Blood Pressure 73.04 72.68
Body Mass Index 26.43 26.20
LDL-C: Low Density Lipoprotein-Cholesterol, HDL-C: High
Density Lipoprotein-Cholesterol.
Table 3 Risk estimate between workers with BLL >40 μg/
dl and BLL ≤40 μg/dl
Variables Adjusted OR CI% 95 P-value
FBS≥ 126 mg/dl 1.00 0.97–1.03 0.68
TG > 200 mg/dl 0.99 0.98–1.00 0.32
LDL-C > 130 mg/dl 0.99 0.98–1.00 0.17
HDL-C < 45 mg/dl 0.99 0.98–1.00 0.49
CHOL > 200 mg/dl 1.00 0.98-1.01 0.96
SBP≥ 140 mmhg 1.01 0.99–1.04 0.12
DBP≥ 90 mmhg 1.03 1.01–1.05 0.05
LDL-C: Low Density Lipoprotein-Cholesterol, HDL-C: High Density Lipoprotein-
Cholesterol, CHOL: cholesterol, TG: Triglyceride, FBS: fasting blood sugar, SBP:
systolic blood pressure, DBP: diastolic blood pressure, OR: odds ratio, CI %95:
%95 confidence interval.
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This result was agreement with some previous studies
[6,19-22], but some studies have shown that there were
opposite effects [23-25].
Our study didn’t show statistically significant differ-
ences in total serum cholesterol and LDL-C level when
comparing 2 groups (workers with BLL > 40 μg/dl and
BLL ≤ 40 μg/dl). These results are consistent with
previous study (34). But some studies have shown
that high total serum cholesterol and LDL-C level to
be more prevalent in the workers with high blood
lead level than the workers with low blood lead level
[6,19,20].
Studies in both humans and animals indicate that
lipid metabolism is altered in chronic lead exposure
[26,27]. The pathophysiological mechanisms invol-
ved in lead induced alterations are not completely
understood.
We found no difference in the prevalence of
hypertriglyceridemia when comparing workers with
BLL ≤ 40 μg/dl and workers with BLL > 40 μg/dl.
Our result was agreement with study by OladipoTable 2 Mean (±SD) of variables in all workers
Variables Mean Standard deviation(±SD)
Fasting Blood Sugar mg/dl 89.22 ± 25.25
Triglyceride mg/dl 164.85 ± 109.92
Cholesterol mg/dl 191.12 ± 55.68
LDL-C mg/dl 117.80 ± 39.40
HDL-C mg/dl 40.96 ± 11.93
Systolic Blood Pressure mmHg 119.00 ± 10.80
Diastolic Blood Pressure mmHg 72.85 ± 7.77
Blood Lead Level μg/dl 43.31 ± 17.95
Body Mass Index 26.31 ± 3.56
LDL-C: Low Density Lipoprotein-Cholesterol, HDL-C: High
Density Lipoprotein-Cholesterol.Ademuyiwa in Nigeria [24]. But some studies have
been shown high serum triglyceride levels to be more
prevalent among workers with BLL > 40 μg/dl than the
workers with BLL ≤ 40 μg/dl [23,25].
In our study, there was no difference in the preva-
lence of HDL-cholesterol level between workers with
BLL > 40 μg/dl and Workers with BLL ≤ 40 μg/dl. So this
result was in agreement with the results in previous study
[23-25]. But Hanne Kirkby et all, found low level of
HDL-C in workers with BLL > 40 μg/dl [21].
We didn’t find difference in the prevalence of
hyperglycemia between workers with BLL ≤ 40 μg/dl and
BLL > 40 μg/dl, so this result in agreement with the
result in previous study [17,18].
But Bener et all found high fasting blood sugar was
more prevalent among workers with BLL > 40 μg/dl than
the workers with BLL ≤ 40 μg/dl [19].
On the basis of the study by our group and other, it is
recommended that in every work place where lead
exposure is mandatory, a lead clinic should be established.
Trained health care personnel of the lead clinic should
monitor intermittently (preferably every six months) the
state of the blood pressure of each lead exposed worker.
Upon discovering significant increases in blood
pressure, especially in diastolic blood pressure a trans-
fer from lead exposed area to non lead exposed area of
at least one year should be recommended to the
employer/management. This would perhaps reduce the
possibilities of ill-effects of lead exposure that are
expected upon the workers.
Attention to this environmental risk factor through
health-protective public policies, workplace modifi-
cations, individual behavioral changes, and also sche-
duling for periodic examination regularly with focusing
on ischemic heart disease risk factors specially diastolic
blood pressure in lead exposed workers is likely to
decrease the public health burden of cardiovascular
disease.
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